Acromegaly is a rare, slowly progressive disorder that is caused when the pituitary glands produce too much growth harmone (GH) in the body. The pituitary gland, located near the base of the skull that store many harmones important for many different functions. Acromegaly is a serious health condition characterized by the growth of benign tumor (adenoma), developing from the pituitary gland.
DelveInsight adds to its newsletter series an Acromegaly addition that centers around the recent details of the Acromegaly market. The newsletter provides a thorough understanding of the Acromegaly market landscape, ongoing clinical trials and pipeline therapies, Acromegaly epidemiological insights and many more details. Dig deep into exploring the Acromegaly domain’s latest news and happenings, mergers and collaborations, major pharmaceuticals involved in the space and licensing deals along with events and top-level conferences combined in the newsletter.
Track fresh updates in the Acromegaly market and how pharma companies are working to push the drug development? Download our Newsletter by simply filling up the form towards the right.
Subscribe to our mailing list and get rich insights delivered every week to you.
Want to explore more? Visit our blog section to get recent updates on Acromegaly Treatment Landscape.
Follow our info-graphics series to get more insights on Acromegaly Market Outlook.
Know more about What's covered:
- Indication overview
- Signs, symptoms, and diagnosis
- Epidemiological trends
- Treatment approaches
- R&D in the field
- Top conferences
- News Flash
- Recent Research Activities
- Support from International organizations
- Market insights
- Market Dynamics
- Collaborations and deals in the domain